Assura PLC Exercise of Nil Cost Options under VCP (6090I)
August 31 2016 - 11:49AM
UK Regulatory
TIDMAGR
RNS Number : 6090I
Assura PLC
31 August 2016
31 August 2016
Assura plc
Exercise of Nil Cost Options under VCP
Assura plc ("Assura"), the leading primary care property
investor and developer announces that on 30 August 2016, all PDMRs
and staff exercised the element of their awards (25% by number) of
the Assura Group Value Creation Plan ("VCP") which were exercisable
under the Rules of the VCP. The remaining nil cost options are
exercisable subject to the achievement of performance hurdles in
2017.
The table below shows the number of nil cost options exercised
by PDMRs, the number of shares sold to satisfy Income Tax and
National Insurance liabilities and the number of shares they will
receive following the sale to satisfy Income Tax and national
insurance liabilities.
Number Number Number
of of shares of shares
Nil Cost sold to receivable
Options satisfy after sale
exercised Income to satisfy
Tax and Income
National Tax and
Insurance National
liabilities Insurance
-------------------------- ----------- ------------- ------------
Jonathan Murphy (Finance
Director) 1,288,356 (605,527) 682,829
-------------------------- ----------- ------------- ------------
Andrew Darke 1,472,407 (692,031) 780,376
-------------------------- ----------- ------------- ------------
The Remuneration Committee of Assura had previously agreed that
sufficient shares may be sold by PDMRs to cover the arising Income
Tax and National Insurance liabilities. The relevant market price
for taxation purposes is 58.65 pence per share being the mid-market
price at close of business on 26 August.
As a result of the above, the increases in the shareholdings of
the PDMRs are as follows:
Shareholding Shareholding
on post exercise
29 August 2016
-------------------------- ---------------- ---------------
Jonathan Murphy (Finance
Director) 957,517 1,640,346
-------------------------- ---------------- ---------------
Andrew Darke 378,739 1,159,115
-------------------------- ---------------- ---------------
The Notification of Dealing Form for each PDMR can be found
below.
This notification is made in accordance with the Market Abuse
Regulation.
Notification of dealing form
1 Details of the person discharging managerial
responsibilities/person closely associated
--- -------------------------------------------------------------
a) Name Jonathan Murphy
--- ------------------------- ----------------------------------
2 Reason for the notification
--- -------------------------------------------------------------
a) Position/status Finance Director
--- ------------------------- ----------------------------------
b) Initial Initial notification
notification/
Amendment
--- ------------------------- ----------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform,
auctioneer or auction monitor
--- -------------------------------------------------------------
a) Name Assura plc
--- ------------------------- ----------------------------------
b) LEI N/A
--- ------------------------- ----------------------------------
4 Details of the transaction(s): section
to be repeated for (i) each type of
instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place
where transactions have been conducted
--- -------------------------------------------------------------
a) Description Ordinary shares of 10 pence
of the each
financial
instrument,
type of
instrument
Identification GB00BVGBWW93
code
--- ------------------------- ----------------------------------
b) Nature
of the Vesting of share awards under
transaction VCP
--- ------------------------- ----------------------------------
c) Price(s) Price(s) Volume(s)
and volume(s) ---------- -----------
GBPNIL
GBP 1,288,356
---------- -----------
--- ------------------------- ----------------------------------
d) Aggregated
information N/A
* Aggregated volume
* Price
--- ------------------------- ----------------------------------
e) Date of 30 August 2016
the transaction
--- ------------------------- ----------------------------------
f) Place of XLON
the transaction
--- ------------------------- ----------------------------------
a) Description Ordinary shares of 10 pence
of the each
financial
instrument,
type of
instrument
Identification GB00BVGBWW93
code
--- ------------------------- ----------------------------------
b) Nature Sale of 605,527 shares to satisfy
of the tax and national insurance
transaction liabilities.
--- ------------------------- ----------------------------------
c) Price(s) Price(s) Volume(s)
and volume(s) ----------- ----------
GBP0.572
GBP 605,527
----------- ----------
--- ------------------------- ----------------------------------
d) Aggregated
information N/A
* Aggregated volume
* Price
--- ------------------------- ----------------------------------
e) Date of 31 August 2016
the transaction
--- ------------------------- ----------------------------------
f) Place of XLON
the transaction
--- ------------------------- ----------------------------------
1 Details of the person discharging managerial
responsibilities/person closely associated
--- -------------------------------------------------------------
a) Name Andrew Darke
--- ------------------------- ----------------------------------
2 Reason for the notification
--- -------------------------------------------------------------
a) Position/status Property Director
--- ------------------------- ----------------------------------
b) Initial Initial notification
notification/
Amendment
--- ------------------------- ----------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform,
auctioneer or auction monitor
--- -------------------------------------------------------------
a) Name Assura plc
--- ------------------------- ----------------------------------
b) LEI N/A
--- ------------------------- ----------------------------------
4 Details of the transaction(s): section
to be repeated for (i) each type of
instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place
where transactions have been conducted
--- -------------------------------------------------------------
a) Description Ordinary shares of 10 pence
of the each
financial
instrument,
type of
instrument
Identification GB00BVGBWW93
code
--- ------------------------- ----------------------------------
b) Nature
of the Vesting of share awards under
transaction VCP
--- ------------------------- ----------------------------------
c) Price(s) Price(s) Volume(s)
and volume(s) ---------- -----------
GBPNIL
GBP 1,472,407
---------- -----------
--- ------------------------- ----------------------------------
d) Aggregated
information N/A
* Aggregated volume
* Price
--- ------------------------- ----------------------------------
e) Date of 30 August 2016
the transaction
--- ------------------------- ----------------------------------
f) Place of XLON
the transaction
--- ------------------------- ----------------------------------
a) Description Ordinary shares of 10 pence
of the each
financial
instrument,
type of
instrument
Identification GB00BVGBWW93
code
--- ------------------------- ----------------------------------
b) Nature Sale of 692,031 shares to satisfy
of the tax and national insurance
transaction liabilities.
--- ------------------------- ----------------------------------
c) Price(s) Price(s) Volume(s)
and volume(s) ----------- ----------
GBP0.572
GBP 692,031
----------- ----------
--- ------------------------- ----------------------------------
d) Aggregated
information N/A
* Aggregated volume
* Price
--- ------------------------- ----------------------------------
e) Date of 31 August 2016
the transaction
--- ------------------------- ----------------------------------
f) Place of XLON
the transaction
--- ------------------------- ----------------------------------
- Ends -
For more information, please contact:
Assura plc Tel: 01925 420660
Orla Ball
Carolyn Jones
Finsbury Tel: 0207 251 3801
Gordon Simpson
Notes to Editors
Assura plc, a constituent of the FTSE 250, is a UK REIT and
long-term investor in and developer of primary care property. The
company, headquartered in Warrington, works with GPs, health
professionals and the NHS to create innovative property solutions
in order to facilitate delivery of high quality patient care in the
community. At 31 March 2016, Assura's property portfolio was valued
at GBP1,111 million.
Further information is available at www.assuraplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCWGUMCRUPQGAG
(END) Dow Jones Newswires
August 31, 2016 11:49 ET (15:49 GMT)
Assura (LSE:AGR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Assura (LSE:AGR)
Historical Stock Chart
From Apr 2023 to Apr 2024
